NEW YORK — The Carlyle Group, a
global asset management firm, is in talks to acquire contract drug developer
Pharmaceutical Product Development Inc. (PPD), Bloomberg
Carlyle has edged out several other
private-equity firms and entered into exclusive talks with the Wilmington,
N.C.-based drug maker, the article stated.
which has a market cap of $3.5 billion, provides contract drug development and
discovery services for pharmaceutical, biotechnology, medical device, academic
and government organizations.